002275 桂林三金
已收盘 05-28 15:00:00
资讯
新帖
简况
桂林三金：数字化项目建设周期通常较长
证券之星 · 05-25
桂林三金：数字化项目建设周期通常较长
股市必读：桂林三金（002275）5月22日董秘有最新回复
证券之星 · 05-25
股市必读：桂林三金（002275）5月22日董秘有最新回复
桂林三金：公司的信息系统会根据业务实际需求进行必要的定制开发，以提升管理效率
中金财经 · 05-22
桂林三金：公司的信息系统会根据业务实际需求进行必要的定制开发，以提升管理效率
桂林三金（002275）披露2025年度股东会决议公告，5月19日股价上涨1.02%
证券之星 · 05-19
桂林三金（002275）披露2025年度股东会决议公告，5月19日股价上涨1.02%
百奥赛图：暂无拓展中药业务的计划，亦无收购桂林三金的计划
每日经济新闻 · 05-14
百奥赛图：暂无拓展中药业务的计划，亦无收购桂林三金的计划
股市必读：桂林三金（002275）5月12日董秘有最新回复
证券之星 · 05-13
股市必读：桂林三金（002275）5月12日董秘有最新回复
股市必读：桂林三金（002275）5月8日董秘有最新回复
证券之星 · 05-11
股市必读：桂林三金（002275）5月8日董秘有最新回复
桂林三金：公司一季度有新增研发项目立项，导致研发费用偏高
证券之星 · 05-08
桂林三金：公司一季度有新增研发项目立项，导致研发费用偏高
每周股票复盘：桂林三金（002275）2025年拟每10股派3元
证券之星 · 05-03
每周股票复盘：桂林三金（002275）2025年拟每10股派3元
桂林三金（002275）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 04-30
桂林三金（002275）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
图解桂林三金年报：第四季度单季净利润同比下降65.20%
证券之星 · 04-29
图解桂林三金年报：第四季度单季净利润同比下降65.20%
桂林三金：截至2026年04月20日股东总户数为18603
证券之星 · 04-23
桂林三金：截至2026年04月20日股东总户数为18603
迈威生物-B(02493)今起招股 君实生物、桂林三金及药明生物等基石认购5300万美元发售股份
智通财经 · 04-20
迈威生物-B(02493)今起招股 君实生物、桂林三金及药明生物等基石认购5300万美元发售股份
桂林三金：截至2026年04月10日股东总户数为18429
证券之星 · 04-15
桂林三金：截至2026年04月10日股东总户数为18429
股市必读：桂林三金(002275)股东户数1.9万户，较上期减少0.7%
证券之星 · 04-07
股市必读：桂林三金(002275)股东户数1.9万户，较上期减少0.7%
桂林三金：公司旗下三金大健康保健食品自产占比约75%
证券之星 · 04-02
桂林三金：公司旗下三金大健康保健食品自产占比约75%
桂林三金（002275）披露为孙公司提供担保的进展公告，3月27日股价上涨1.43%
证券之星 · 03-27
桂林三金（002275）披露为孙公司提供担保的进展公告，3月27日股价上涨1.43%
桂林三金：截至2026年03月20日股东总户数为19179
证券之星 · 03-25
桂林三金：截至2026年03月20日股东总户数为19179
桂林三金：截至2026年02月27日股东总户数为18823
证券之星 · 03-02
桂林三金：截至2026年02月27日股东总户数为18823
桂林三金：三金西瓜霜牙膏为上市公司旗下全资子公司桂林三金日化健康产业有限公司的产品
证券之星 · 03-02
桂林三金：三金西瓜霜牙膏为上市公司旗下全资子公司桂林三金日化健康产业有限公司的产品
暂无数据
公司概况
公司名称：
桂林三金药业股份有限公司
所属行业：
医药制造业
上市日期：
2009-07-10
主营业务：
桂林三金药业股份有限公司的主营业务是中成药的研发、制造与销售。公司的主要产品是三金片、桂林西瓜霜、西瓜霜润喉片、西瓜霜清咽含片、眩晕宁片/颗粒、蛤蚧定喘胶囊、拉莫三嗪片（安闲）、脑脉泰胶囊、玉叶解毒颗粒、复方田七胃痛胶囊。
发行价格：
19.80
{"stockData":{"symbol":"002275","market":"SZ","secType":"STK","nameCN":"桂林三金","latestPrice":13.24,"timestamp":1779951828000,"preClose":13.43,"halted":0,"volume":1886503,"delay":0,"changeRate":-0.0141,"floatShares":557000000,"shares":588000000,"eps":0.7705,"marketStatus":"已收盘","change":-0.19,"latestTime":"05-28 15:00:00","open":13.38,"high":13.49,"low":13.22,"amount":25125300,"amplitude":0.0201,"askPrice":13.26,"askSize":133,"bidPrice":13.24,"bidSize":80,"shortable":0,"etf":0,"ttmEps":0.7705,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780018200000},"marketStatusCode":5,"adr":0,"adjPreClose":13.43,"symbolType":"stock","openAndCloseTimeList":[[1779931800000,1779939000000],[1779944400000,1779951600000]],"highLimit":14.77,"lowLimit":12.09,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":587568600,"isCdr":false,"pbRate":2.37,"roa":"--","peRate":17.183647,"roe":"3.82%","epsLYR":0.74,"committee":0.390158,"marketValue":7779000000,"turnoverRate":0.0034,"status":1,"floatMarketCap":7376000000},"requestUrl":"/m/hq/s/002275/tweets","defaultTab":"tweets","newsList":[{"id":"2638538258","title":"桂林三金：数字化项目建设周期通常较长","url":"https://stock-news.laohu8.com/highlight/detail?id=2638538258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638538258?lang=zh_cn&edition=full","pubTime":"2026-05-25 15:12","pubTimestamp":1779693153,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好！年报提到多个数字项目处于建设期与收益期的错配阶段，这对公司短期财务表现产生了哪些具体压力？公司预计何时能够实现数字化投入的产出平衡？桂林三金回复：您好，数字化项目建设周期通常较长，虽涉及一定成本支出及折旧摊销，但占公司总体费用比重不大，随着项目持续推进，将有效提高公司管理效率、降低运营成本，助力公司整体经营效益稳步提升，谢谢。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500014937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0060","BK0239","002275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638575300","title":"股市必读：桂林三金（002275）5月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2638575300","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638575300?lang=zh_cn&edition=full","pubTime":"2026-05-25 05:00","pubTimestamp":1779656436,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，桂林三金报收于13.54元，下跌0.44%，换手率0.33%，成交量1.84万手，成交额2503.57万元。董秘最新回复投资者： 您好！公司积极推动与供应商的协同对接，逐步提升供应链整体的数字化联动能力，谢谢。交易信息汇总资金流向5月22日主力资金净流入18.89万元；游资资金净流入122.5万元；散户资金净流出141.39万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500002060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","BK0188","BK0239","002275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637836096","title":"桂林三金：公司的信息系统会根据业务实际需求进行必要的定制开发，以提升管理效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2637836096","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637836096?lang=zh_cn&edition=full","pubTime":"2026-05-22 12:44","pubTimestamp":1779425060,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！标准化ERP/MES系统在满足中药材批次追溯、效期管控等特殊需求时，是否需要大量定制开发？同时咱上游中药材供应商的信息化水平能否与公司的供应链协同平台有效对接？谢谢～桂林三金回复：您好，公司的信息系统会根据业务实际需求进行必要的定制开发，以提升管理效率。公司积极推动与供应商的协同对接，逐步提升供应链整体的数字化联动能力，谢谢。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260522/32246363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","BK0188","BK0060","002275","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636850308","title":"桂林三金（002275）披露2025年度股东会决议公告，5月19日股价上涨1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636850308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636850308?lang=zh_cn&edition=full","pubTime":"2026-05-19 22:59","pubTimestamp":1779202751,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，桂林三金报收于13.89元，较前一交易日上涨1.02%，最新总市值为81.61亿元。该股当日开盘13.75元，最高13.94元，最低13.71元，成交额达2458.37万元，换手率为0.32%。桂林三金于近日披露《2025年度股东会决议公告》。会议采用现场与网络投票结合方式，出席股东及授权代表共78人，代表股份占公司有表决权股份总数的70.0352%。所有议案均获通过，无否决议案。北京市通商律师事务所对会议进行了见证并出具法律意见书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900044431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","BK0188","BK0239","002275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635791211","title":"百奥赛图：暂无拓展中药业务的计划，亦无收购桂林三金的计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2635791211","media":"每日经济新闻","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635791211?lang=zh_cn&edition=full","pubTime":"2026-05-14 15:43","pubTimestamp":1778744598,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：桂林三金作为贵司基石投资者，贵公司跟三金有无业务合作往来，贵公司有没有想法收购三金这种中华老字号来拓展中药类的业务。百奥赛图（688796.SH）5月14日在投资者互动平台表示，桂林三金作为公司港股IPO的基石投资者，是对公司长期价值的认可。公司是一家创新技术驱动新药研发的国际性生物技术公司，旨在为新药研发领域提供高品质的产品与服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605143737373671.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605143737373671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0060","BK0239","BK0188","688796","BK0028","002275","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635249017","title":"股市必读：桂林三金（002275）5月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2635249017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635249017?lang=zh_cn&edition=full","pubTime":"2026-05-13 01:33","pubTimestamp":1778607188,"startTime":"0","endTime":"0","summary":"截至2026年5月12日收盘，桂林三金报收于14.47元，下跌1.43%，换手率0.35%，成交量1.98万手，成交额2875.31万元。宝船生物于2025年4月收到国家药品监督管理局为BC006单抗注射液新增加的适应症核准签发的临床试验批件，同意本品开展用于特发性肺纤维化适应症的临床试验，该适应症临床试验目前处于I期临床试验阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300001746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002275","BK0239","BK0060","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634293414","title":"股市必读：桂林三金（002275）5月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2634293414","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634293414?lang=zh_cn&edition=full","pubTime":"2026-05-11 03:51","pubTimestamp":1778442670,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，桂林三金报收于14.49元，上涨0.62%，换手率0.4%，成交量2.25万手，成交额3258.41万元。董秘最新回复投资者： 贵公司一季度研发费9千万，请说明一下为什么这么高？董秘： 您好，截至2026年04月30日股东总户数为18263，谢谢。交易信息汇总资金流向5月8日主力资金净流入162.01万元；游资资金净流入275.17万元；散户资金净流出437.17万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","002275","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633337434","title":"桂林三金：公司一季度有新增研发项目立项，导致研发费用偏高","url":"https://stock-news.laohu8.com/highlight/detail?id=2633337434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633337434?lang=zh_cn&edition=full","pubTime":"2026-05-08 16:21","pubTimestamp":1778228480,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)05月08日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司一季度研发费9千万，请说明一下为什么这么高？桂林三金回复：您好，公司一季度有新增研发项目立项，导致研发费用偏高，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800028329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0028","002275","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632608992","title":"每周股票复盘：桂林三金（002275）2025年拟每10股派3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632608992","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632608992?lang=zh_cn&edition=full","pubTime":"2026-05-03 08:20","pubTimestamp":1777767621,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，桂林三金报收于14.31元，较上周的14.0元上涨2.21%。本周，桂林三金4月30日盘中最高价报14.41元。股本股东变化股东户数变动截至2026年4月20日，桂林三金股东户数为1.86万户，较4月10日增加174.0户，增幅0.94%。公司公告汇总关于2025年度利润分配方案及2026年中期现金分红规划的公告桂林三金于2026年4月27日召开第九届董事会第二次会议，审议通过2025年度利润分配方案及2026年中期现金分红规划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300002057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0239","002275","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631101520","title":"桂林三金（002275）2026年一季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2631101520","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631101520?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:29","pubTimestamp":1777501769,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期桂林三金发布2026年一季报。截至本报告期末，公司营业总收入5.25亿元，同比上升12.55%，归母净利润1.24亿元，同比上升18.64%。本报告期桂林三金盈利能力上升，毛利率同比增幅5.79%，净利率同比增幅5.41%。去年的净利率为21.17%，算上全部成本后，公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000020713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631580306","title":"图解桂林三金年报：第四季度单季净利润同比下降65.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631580306","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631580306?lang=zh_cn&edition=full","pubTime":"2026-04-29 02:44","pubTimestamp":1777401859,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金2025年年报显示，当年度公司主营收入20.46亿元，同比下降6.76%；归母净利润4.33亿元，同比下降16.95%；扣非净利润4.09亿元，同比上升3.23%；其中2025年第四季度，公司单季度主营收入5.83亿元，同比下降5.79%；单季度归母净利润4790.7万元，同比下降65.2%；单季度扣非净利润5619.66万元，同比上升14.0%；负债率25.06%，投资收益525.0万元，财务费用110.71万元，毛利率76.03%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900007217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629848883","title":"桂林三金：截至2026年04月20日股东总户数为18603","url":"https://stock-news.laohu8.com/highlight/detail?id=2629848883","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629848883?lang=zh_cn&edition=full","pubTime":"2026-04-23 15:33","pubTimestamp":1776929590,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)04月23日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，您好！敬请发布截至今天4月中旬末公司股东户数信息。谢谢！致礼！桂林三金回复：您好，截至2026年04月20日股东总户数为18603，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300038113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002275","BK0239","BK0060","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628799412","title":"迈威生物-B(02493)今起招股 君实生物、桂林三金及药明生物等基石认购5300万美元发售股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2628799412","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628799412?lang=zh_cn&edition=full","pubTime":"2026-04-20 06:34","pubTimestamp":1776638067,"startTime":"0","endTime":"0","summary":"2025年8月，迈利舒及迈卫健获巴基斯坦药品监管局上市批准。迈利舒及迈卫健是在巴基斯坦获批的首个Prolia及Xgeva生物类似药。于2024年及2025年，净亏损分别为约10.47亿元及9.72亿元，主要由于研发活动所产生的成本及开支。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430395.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0039217434.USD","LU0348735423.USD","LU1688375341.USD","BK1583","LU1880383366.USD","688180","BK0060","BK1610","LU1720050803.USD","LU0572944931.SGD","BK1161","01877","LU0051755006.USD","LU0181495838.USD","002275","LU0516422366.SGD","LU0979878070.USD","LU0516423174.USD","02493","BK1576","LU0516423091.SGD","LU0326950275.SGD","02269","LU0417516902.SGD","LU0140636845.USD","BK1589","LU0823426308.USD","LU0327786744.USD","SG9999002463.SGD","BK0188","BK0028","BK1515","LU0307460666.USD","LU0819121731.USD","LU0823426480.USD","LU0043850808.USD","BK0239","LU2039709279.SGD","LU0456846285.SGD","LU0588546209.SGD","LU1242518857.USD","LU0856984785.SGD","LU0516422440.USD","LU1794554557.SGD","SG9999002562.SGD","LU3063872942.SGD","688062","LU0456827905.SGD","LU0417516738.SGD","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627409404","title":"桂林三金：截至2026年04月10日股东总户数为18429","url":"https://stock-news.laohu8.com/highlight/detail?id=2627409404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627409404?lang=zh_cn&edition=full","pubTime":"2026-04-15 15:27","pubTimestamp":1776238035,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)04月15日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到2026年4月10日公司的股东人数是多少?谢谢桂林三金回复：您好，截至2026年04月10日股东总户数为18429，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500022284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","BK0239","002275","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625067846","title":"股市必读：桂林三金(002275)股东户数1.9万户，较上期减少0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625067846","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625067846?lang=zh_cn&edition=full","pubTime":"2026-04-07 03:20","pubTimestamp":1775503226,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，桂林三金报收于14.3元，下跌2.26%，换手率0.53%，成交量2.99万手，成交额4314.35万元。股本股东变化股东户数变动近日桂林三金披露，截至2026年3月31日公司股东户数为1.9万户，较3月20日减少134.0户，减幅为0.7%。户均持股数量由上期的3.06万股增加至3.09万股，户均持股市值为44.67万元。董秘最新回复投资者： 请问公司3月31日股东人数，谢谢董秘： 您好，截至2026年03月31日股东总户数为19045，谢谢。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700002189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0060","BK0188","002275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624574188","title":"桂林三金：公司旗下三金大健康保健食品自产占比约75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624574188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624574188?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:55","pubTimestamp":1775120105,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金04月02日在投资者关系平台上答复投资者关心的问题。买来后发现多数生产地都在桂林，基本上都是公司自产的嘛，自产和贴牌大致占比多少？现在保健品这块一共有有多少批文，赢利状况如何？桂林三金回复：您好，公司旗下三金大健康保健食品自产占比约75%，主要产品如西瓜霜喉口宝含片、保肝胶囊、营养素系列等产品均为自产。三金大健康目前拥有保健食品批文42个，近三年因市场原因营收收窄，但仍处于盈利状况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200027830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002275","BK0239","BK0060","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622878618","title":"桂林三金（002275）披露为孙公司提供担保的进展公告，3月27日股价上涨1.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622878618","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622878618?lang=zh_cn&edition=full","pubTime":"2026-03-27 22:29","pubTimestamp":1774621788,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，桂林三金报收于14.18元，较前一交易日上涨1.43%，最新总市值为83.32亿元。近日，桂林三金药业股份有限公司发布《关于为孙公司提供担保的进展公告》。本次担保在公司2025年度股东大会批准的对白帆生物最高2亿元担保额度内，担保期限自2026年3月30日至2031年3月29日。公司未对合并报表外单位提供担保，无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700050228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002275","BK0239","BK0188","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622882025","title":"桂林三金：截至2026年03月20日股东总户数为19179","url":"https://stock-news.laohu8.com/highlight/detail?id=2622882025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622882025?lang=zh_cn&edition=full","pubTime":"2026-03-25 16:09","pubTimestamp":1774426152,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)03月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司3月20日最新股东人数是多少，谢谢桂林三金回复：您好，截至2026年03月20日股东总户数为19179，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500029304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","002275","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616801125","title":"桂林三金：截至2026年02月27日股东总户数为18823","url":"https://stock-news.laohu8.com/highlight/detail?id=2616801125","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616801125?lang=zh_cn&edition=full","pubTime":"2026-03-02 11:54","pubTimestamp":1772423649,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 新年好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年2月27日A股股东人数是多少？谢谢桂林三金回复：您好，截至2026年02月27日股东总户数为18823，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200013426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0028","BK0239","002275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616380114","title":"桂林三金：三金西瓜霜牙膏为上市公司旗下全资子公司桂林三金日化健康产业有限公司的产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2616380114","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616380114?lang=zh_cn&edition=full","pubTime":"2026-03-02 11:54","pubTimestamp":1772423649,"startTime":"0","endTime":"0","summary":"证券之星消息，桂林三金(002275)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，请问三金西瓜霜牙膏是属于上市公司投资生产的吗？桂林三金回复：您好，三金西瓜霜牙膏为上市公司旗下全资子公司桂林三金日化健康产业有限公司的产品，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200013427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0028","002275","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779978860769,"stockEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.038},{"period":"3month","weight":-0.0712},{"period":"6month","weight":-0.1076},{"period":"1year","weight":-0.0267},{"period":"ytd","weight":-0.0475}],"compareEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":0.0018},{"period":"3month","weight":-0.0128},{"period":"6month","weight":0.0528},{"period":"1year","weight":0.2254},{"period":"ytd","weight":0.0315}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"桂林三金药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18263人(较上一季度减少1.83%)","perCapita":"30504股","listingDate":"2009-07-10","address":"广西壮族自治区桂林市临桂区人民南路9号","registeredCapital":"58756万元","survey":" 桂林三金药业股份有限公司的主营业务是中成药的研发、制造与销售。公司的主要产品是三金片、桂林西瓜霜、西瓜霜润喉片、西瓜霜清咽含片、眩晕宁片/颗粒、蛤蚧定喘胶囊、拉莫三嗪片（安闲）、脑脉泰胶囊、玉叶解毒颗粒、复方田七胃痛胶囊。","listedPrice":19.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"桂林三金(002275)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供桂林三金(002275)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"桂林三金,002275,桂林三金股票,桂林三金股票老虎,桂林三金股票老虎国际,桂林三金行情,桂林三金股票行情,桂林三金股价,桂林三金股市,桂林三金股票价格,桂林三金股票交易,桂林三金股票购买,桂林三金股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"桂林三金(002275)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供桂林三金(002275)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}